Sfoglia per Autore
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action.
2009-01-01 Biava, M; Porretta, Gc; Poce, G; DE LOGU, Alessandro; Manetti, F; Botta, M.
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents.
2009-01-01 Poce, G; Porretta, Gc; DE LOGU, Alessandro; De Rossi, E; Manetti, F; Botta, M; Biava, M.
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials.
2009-01-01 Poce, G; Porretta, Gc; Borzi, F; DE LOGU, Alessandro; De Rossi, E; Manetti, F; Botta, M; Biava, M.
Effetto di FANS sulla formazione di biofilm di Candida albicans e potenziamento della attività di farmaci antifungini
2009-01-01 Agus, E; Piras, Cc; Casula, L; Serra, N; DE LOGU, Alessandro
ASPETTI MICROBIOLOGICI DELLA PRODUZIONE FARMACEUTICA
2009-01-01 DE LOGU, Alessandro
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis
2009-01-01 DE LOGU, Alessandro; Palchykovska L., H; Kostina V., H; Sanna, A; Meleddu, Rita; Chisu, L; Alexeeva I., V; Shved, A. D.
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation
2009-01-01 Onnis, Valentina; DE LOGU, Alessandro; Cocco, Mt; Fadda, R; Meleddu, Rita; Congiu, Cenzo
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones
2009-01-01 Castagnolo, D; Manetti, F; Radi, M; Bechi, B; Pagano, M; DE LOGU, Alessandro; Meleddu, Rita; Saddi, M; Botta, M.
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation
2009-01-01 Biava, M; Porretta, Gc; Poce, G; DE LOGU, Alessandro; Meleddu, Rita; DE ROSSI, E; Manetti, F; Botta, M.
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis
2009-01-01 Castagnolo, D; Radi, M; Dessì, F; Manetti, F; Saddi, M; Meleddu, Rita; DE LOGU, Alessandro; Botta, M.
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation
2009-01-01 Zaru, M; Sinico, Chiara; DE LOGU, Alessandro; Caddeo, Carla; Lai, Francesco; Manca, MARIA LETIZIA; Fadda, ANNA MARIA
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents
2008-01-01 Biava, M; Porretta G., C; Poce, G; DE LOGU, Alessandro; Meleddu, Rita; De Rossi, E; Manetti, F; Botta, M.
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings
2008-01-01 Biava, M; Porretta, Gc; Poce, G; DE LOGU, Alessandro; Saddi, M; Meleddu, Rita; Manetti, F; DE ROSSI, E; Botta, M.
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis
2008-01-01 Castagnolo, D; DE LOGU, Alessandro; Radi, M; Bechi, B; Manetti, F; Magnani, M; Supino, S; Meleddu, Rita; Chisu, L; Botta, M.
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO
2007-01-01 Saddi, M; Meleddu, Rita; Sanna, A; Chisu, L; DE LOGU, Alessandro
SLN as a topical delivery system for Artemisia arborescens essential oil: In vitro antiviral activity and skin permeation study
2007-01-01 Lai, Francesco; Sinico, Chiara; DE LOGU, Alessandro; Zaru, Marco; Mueller, Rainer; Fadda, ANNA MARIA
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero
2007-01-01 Saddi, M; Meleddu, R; Sanna, A; Chisu, L; DE LOGU, Alessandro
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells
2007-01-01 Saddi, M; Sanna, Adriana; Cottiglia, Filippo; Chisu, L; Casu, Laura; Bonsignore, L; DE LOGU, Alessandro
Attività intramacrofagica di nuovi agenti antitubercolari per il trattamento delle infezioni sostenute da ceppi MDR mediante inibizione selettiva della RNA polimerasi.
2006-01-01 Saddi, M; Palchykovska, Lh; Chisu, L; Kostina, Vh; Shestakova, Ts; Alexeeva, Iv; Saddi, B; Shved, Ad; DE LOGU, Alessandro
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico.
2006-01-01 Chisu, L; Cardia, Mc; Saddi, M; Saddi, B; Maccioni, Elias; DE LOGU, Alessandro
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile